C22ORF15 anticorps (AA 61-148) (FITC)

N° du produit ABIN1709103

Détail du produit anti-C22ORF15 anticorps (FITC)

Antigène: C22ORF15 (Chromosome 22 Open Reading Frame 15 (C22ORF15))

Épitope: AA 61-148

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C22ORF15 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human C22orf15

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur C22ORF15

Antigène: C22ORF15 (Chromosome 22 Open Reading Frame 15 (C22ORF15))

Autre désignation: C22orf15 (C22ORF15 Produits)

Synonymes: anticorps N27C7-3, anticorps chromosome 22 open reading frame 15, anticorps C22orf15

Sujet:

Synonyms: C22orf15, chromosome 22 open reading frame 15, CV015_HUMAN, N27C7 3, Protein N27C7-3, Uncharacterized protein C22orf15.

Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf15 gene product has been provisionally designated C22orf15 pending further characterization.

ID gène: 150248